An experimental diet drug looks like a long-distance success. New data indicate that obese adults who lose weight during a year of taking rimonabant and dieting keep the weight off during the following year, if they continue the regimen.
The drug, which Paris-based manufacturer Sanofi-Aventis calls Acomplia, blocks cells’ receptors for chemicals called cannabinoids, which include substances in marijuana.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.